Comparative analysis of the targets for reducing adult population mortality by 2024

Introduction. Currently, in the Russian Federation there are realized national projects “Healthcare” and “Demography” aimed at reducing the mortality. For implementation at the regional level in Moscow, there have been developed regional programs with appropriate regional indicators.

The purpose of the study is to assess the degree of achievement of the targets of national, federal and regional adult mortality rates.

Materials and methods. The study is based on a comparative analysis of targets and actual statistical data.

Results. In Moscow and in Russia, there is a decrease in mortality from all causes, diseases of the circulatory system, myocardial and cerebral infarction, neoplasms. Despite the increase in the level in 2020–2021 due to the pandemic, in 2022, mortality rates returned to the pre-pandemic period and have a tendency to further decrease. Current trends point to the high achievability of targets in Moscow, while in the country, most indicators have a chance of not being achieved. In Moscow there is noted a higher cancer mortality rate i to which a significant contribution may be made by cancer patients from other Russian regions who receive medical care in federal cancer centers located in Moscow and who died on its territory.

Research limitations. Standardized mortality rates of the population were calculated in the FAISS internal use program.

Conclusion. The implementation of national, federal and regional projects has had a positive impact on the effectiveness of demographic policy to reduce mortality.

Compliance with ethical standards. This type of research does not require an examination by the local ethics committee.

Contribution of the authors:
Savina A.A. — research concept and design, statistical processing, text writing;
Feiginova S.I. — research design, text writing, editing, translation, compilation of the list of references;
Grigorov A.A. — research concept, editing.
All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.

Acknowledgment. The study had no sponsorship.

Conflict of interest. The authors declare that there is no conflict of interest.

Received: May 31, 2024 / Accepted: October 3, 2024 / Published: November 6, 2024